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Background: Toxoplasma gondii is an intracellular coccidian parasite that causes toxoplasmosis. It was estimated
that more than one third of the world population is infected by T. gondii, and the disease is critical in fetuses and
immunosuppressed patients. Thus, early detection is crucial for disease diagnosis and therapy. However, the current
available toxoplasmosis diagnostic tests vary in their accuracy and the better ones are costly.
Results: An earlier published work discovered a highly antigenic 12 kDa excretory-secretory (ES) protein of T. gondii
which may potentially be used for the development of an antigen detection test for toxoplasmosis. However, the
three-dimensional structure of the protein is unknown. Since epitope identification is important prior to designing
of a specific antibody for an antigen-detection based diagnostic test, the structural elucidation of this protein is
essential. In this study, we constructed a three dimensional model of the 12 kDa ES protein. The built structure
possesses a thioredoxin backbone which consists of four α-helices flanking five β-strands at the center. Three
potential epitopes (6–8 residues) which can be combined into one “single” epitope have been identified from the
built structure as the most potential antibody binding site.
Conclusion: Together with specific antibody design, this work could contribute towards future development of an
antigen detection test for toxoplasmosis.
Keywords: Toxoplasma gondii, Excretory-secretory protein, Homology modeling, Epitope prediction,
Molecular dockingBackground
Toxoplasmosis is a disease caused by the intracellular
protozoan parasite, Toxoplasma gondii. The disease is
estimated to infect more than one-third of the world
population [1-5]. Although the infection may show mild
symptoms or asymptomatic [6], it can be fatal in an im-
munocompromised patient or the fetus whose mother
acquired primary infection during pregnancy [7]. The
life cycle of T. gondii can be divided into two phases,
sexual and asexual phase. The sexual phase o the life
cycle of T. gondii occurs only in cats (felids; the primary
host). The asexual phase occurs in other warm-blooded
animals (including humans) where it transmits through
food contaminated with the feces of infected cats [8].* Correspondence: yeesiew@usm.my
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reproduction in any medium, provided the orDue to the high prevalence of toxoplasmosis, espe-
cially in third world countries, disease diagnosis and
therapy are important. There are a number of diagnostic
methods available which include IgM-ELISA, IgG-
ELISA, IgG avidity test, Western blots and PCR using
body fluids and tissues [9]. Some of these methods are
time consuming, expensive and vary in their accuracy to
diagnose acute infection.
An earlier published work has led to the discovery
of a low molecular weight, highly antigenic 12 kDa
excretory-secretory (ES) protein from T. gondii which is
of potential to be used as a diagnostic marker to detect
active infection. The antigenicity of the protein could
lead to the development of an antigen or antibody detec-
tion test [4]. ES proteins are also known to be better
antigens in diagnostic systems such as ELISA compared
to crude antigens or somatic antigens as detection sensi-
tivity are improved [10]. It was also found to be morel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Tommy et al. BMC Structural Biology 2012, 12:30 Page 2 of 9
http://www.biomedcentral.com/1472-6807/12/30effective in the diagnosis of swine trichinosis, toxocaria-
sis, and ornithobilharziosis [11-13].
Development of an antigen detection test requires
identification of B-cell epitope involved in antibody rec-
ognition. In order to identify the epitope(s), we modeled
the three-dimensional structure of the 12 kDa ES pro-
tein of T. gondii. The results showed that the 12 kDa ES
protein has a thioredoxin-like backbone and consist of
three potential epitopes which function as a “single”
antibody binding site.
The 12 kDa protein was also analyzed for its molecular
docking capacity with apoptosis signal-regulating kinase
1 (ASK1) using ZDOCK, PatchDock and FireDock.
Docking results showed that the predicted epitopes
scored as the best ranked complex.
Results
Protein structure prediction
The 12 kDa ES protein consists of 106 amino acids. The
result of BLAST against non-redundant (nr) protein
database showed that the ES protein has a sequence
identity of 46-79% with thioredoxin protein family of
Neospora caninum, Plasmodium spp and Saccharomyces
cerevisiae (Table 1). From the BLAST search against
PDB, five best templates were selected. The selected
templates had sequence identities of at least 37%. Tem-
plates selected were 3F3Q [14], 2I9H [15], 3F3R [14],
2FA4 [16] and 2HSY [17]. All the templates were
obtained from S. cerevisiae (Table 2).
Sequence identity above 30% is sufficient to be used as
templates for homology modeling technique [18-20].
The selected templates mentioned above were appropri-
ate, especially since the sequence length of the ES pro-
tein is only 106 residues. Results of secondary structure
prediction from all prediction servers were similar in
terms of the total number of β-sheets and α-helices for
the ES protein. The locations of the β-sheets and α-heli-
ces predicted were also found to be similar. The only
difference in results from the servers was by Prof Server
where an α-helix was predicted to be a β-sheet instead
(Table 3).
Results from PROCHECK Ramachandran plot and
verify3D showed that the best built model after energy
minimization had 95.8% of the residues falling in the
fully allowed region, 4.2% of the residues in the allowedTable 1 Results from non-redundant protein database BLAST





NP_013144.1 46/69region and 0% in generously allowed and disallowed
regions. Results with > 90% of the residues in the fully
allowed region and none falling on disallowed region
indicates that the model is well built [21]. Verify3D test
results showed that 100% of the residues had an average
3D-1D score higher than 0.2 which indicates a well built
model since all the residues are valid in their folded con-
formation (Figure 1). PROCHECK evaluation showed
−0.02 G-factor score for the 3D model of the ES protein.
A model with an overall scores of G-factor higher that
of −0.5 is accepted in general as an indication of a good
quality model [21]. STRIDE result for secondary struc-
ture calculation also correlated well with the result of se-
quence based secondary structure prediction by the
three servers mentioned above (Table 3).
The 3-dimensional structure of the 12 kDa ES protein
is an assembly of four α-helices (α1-α4) and five β-
sheets (β1-β5) (Figure 2a). The β-sheets are flanked by
the α-helices with all the loops and turns connecting the
helices and sheets located on the surface of the struc-
ture. All the sheets are almost parallel to each other
pairing with α2 and α4 while α1 and α3 are oriented
perpendicularly.
Epitope prediction
Epitopes of the ES protein were predicted using four dif-
ferent servers for both linear and conformational epitope
predictions. Average accuracy of these prediction servers
were reported to be 75% [22]. Epitope prediction servers
showed comparable results. There were a few regions of
the ES proteins that were predicted to be potential epi-
topes by at least three servers. Three out of the four ser-
vers predicting a region to be an epitope shows
convincing result. From the result of the prediction, we
can conclude that the five most possible epitopes are
residue 6–14, 28–35, 47–52, 71–76 and 91–98
(Figure 2b & 2c). Residue 91 was considered as one of
the epitope residue even with only two epitope predic-
tion servers predicting it to be an epitope because it is
an important residue shown in previously published
work [23]. Val91 is important because it might be
involved in the binding of thioredoxin to other protein
molecule due to its accessibility [23].
Protein binding site prediction server, ProBis, pre-
dicted that 2 of the above mentioned 5 epitopes to besearch of the T. gondii.12 kDa ES protein
Organism of origin Title E-values
Neospora caninum Thioredoxin 1e-47
Plasmodium falciparum Thioredoxin 6e-26
Plasmodium knowlesi Thioredoxin 8e-25
Plasmodium vivax Thioredoxin 3e-24
Saccharomyces cerevisiae Thioredoxin1p 4e-22
Table 2 Templates from BLAST search against Protein Data Bank (PDB) for the three-dimensional structure


















Chain A, Nmr Solution Structure Of Thioredoxin 1 9e-25 NA
3F3R14 46/69 Saccharomyces
cerevisiae
Chain A, Crystal Structure Of Yeast Thioredoxin1-




Chain A, Crystal Structure Of Oxidized Form 2e-20 2.4
2HSY17 37/69 Saccharomyces
cerevisiae
Chain A, Solution Structure Of Thioredoxin 2 2e-20 NZ
NA: Not applicable.
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showed that residue 27–35 and 73–77 are the protein
binding sites.
Molecular docking
ASK1 is a member of the mitogen-activated protein kin-
ase kinase (MAPKKK) family. It is involved in the map
kinase pathway where it activates certain kinase in re-
sponse to stress [24]. A protein-protein docking simula-
tion was performed by docking the modeled ES protein
with ASK1 to further improve the confidence of the epi-
topes predicted from the ES protein. ASK1 was chosen
as the docking partner of built ES protein as thioredoxin
has been identified to be an ASK1-interacting molecule
that plays an important role in oxidative stress-induced
regulation of ASK1 [24]. Results from molecular dockingTable 3 Secondary structure prediction from the sequence an
of the T. gondii 12 kDa ES protein
1 6 11 16 21 26
Sequence MPVHH VTTEA QFKSL IEENE MVLVD FYA
Jpred –BBB B–AA AAAAA AAA– -BBBB BB—
PORTER —BB B–AA AAAAA AA— BBBBB BB—
Prof –BBB BB— AAAAA AA— BBBBB BB—
APSSP2 –BB- -AAAA AAAAA A–BB BBBBB ——
STRIDE —BB —AA AAAAA AA— BBBBB BB—
Built Model —BB —AA AAAAA AA— BBBBB BB—
61 66 71 76 81 86
Sequence DELAD VAERE EINAM PTFKL FKQGK AV
Jpred ——A AAAAA ——— -BBBB BB— BBB
PORTER —AA AAAA- ——— -BBBB BB–B BBB
Prof BBBBB BBBBB ——— BBBBB BB— BBB
APSSP2 -AAAA AAA– BBBBB BBBBB -BBBB BBB
STRIDE –AAA AAAAA ——— -BBBB BB–B BBB
Built Model –AAA AAAAA ——— -BBBB BB–B BBB
B = Beta Sheets.
A = Alpha Helices.of ES protein and ASK1 showed that our ES protein
binds to ASK1. From ZDOCK, 2000 docking complexes
were generated and were ranked from the best binding
complex to the worst binding complex. The best ranked
complex (Figure 3) showed that ES protein binds to the
ASK1 on residue 28–35, 71–76 and 91–98. On the other
hand, PatchDock provided results which were ranked
according to a geometric shape complementarily score
after molecular shape representation and surface patch
matching [25]. These results were used for further re-
finement and re-scoring of 1000 top scoring complexes
using FireDock [26,27]. The results from Firedock
ranked the complexes according to the global energy
score. The best ranked complex has a score of −25.62
which is generally good [26]. The complex showed that
the ES protein was bound to ASK1 on the same residuesd secondary structure calculation from the built structure
31 36 41 46 51 56
VW CGPCR QVAPL VEAMS EKPEY AKVKF VKIDV
—AA AAAAA AAAAA AAA– —BB BBBB-
-AAAA AAAAA AAAAA AA— —BB BBBB-
—AA AAAAA AAAAA AA— –BBB BBBBB
— -AAAA AAAAA AAAAA A—— BBBBB BB—
-AAAA AAAAA AAAAA A—— –BBB BBBB-
-AAAA AAAAA AAAAA A—— –BBB BBBB-
91 96 101 106
DTV VGANA ERVEE MVKKH L
BB ——A AAAAA AAAA- -
BB B—A AAAAA AAAA- -
BB ——A AAAAA AAAA- -
– –AAA AAAAA AA— -
BB B—A AAAAA AAAAA -
BB B—A AAAAA AAAAA -
Figure 1 Verify3D results for final built 12 kDa ES protein model. All the residues 3D-1D score are higher than 0.2 with 0.23 as the lowest
score of the residues.
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and 91–98). These epitopes were predicted by the epi-
tope prediction servers as well as ProBis. Further ana-
lysis of the interaction between the ES protein and
ASK1 shows spatial distances ranging between 4.3 Å and
8.4 Å from the important residues of ES protein (Gly-32,
Pro-33, Ile-74, Pro-76, Val-91, Gly-92, Ala-93) with resi-
dues from ASK1.
Discussion
Elucidating the structure of the 12 kDa ES protein from
T. gondii is necessary to understand the functionality of
the antigen. It is interesting to find that BLAST against
nr protein database and PDB database, showed the
12 kDa ES protein has high sequence identity with thior-
edoxin proteins. It is the most abundant cellular-
reducing dithiol catalyst which functions include redox
regulation, protein folding, intracellular signaling and
oxidative stress responses. The thioredoxin family is a
large family of proteins consisting of domains that func-
tion biochemically by forming disulfide bonds with tar-
get molecules, resulting in conformational changes or
rearrangement of disulfide bonds in the target. In cancer
studies Trxs have been proposed as drug targets. Fur-
thermore, components of the redox cycle have been
considered targets in malaria parasites and trypanosoma-
tids. The ES protein has also been identified to be
mainly localized at the outer compartment of T.gondii
apicoplast and it is discovered that an Apicoplast
Thioredoxin-like protein 1 (ATrx1) was the first protein
found to reside in apicoplast intermembrane spaces. Sev-
eral enzymes found in the apicoplast that are potentially
regulated by thioredoxin including 1-deoxy-d-xylulose 5-
reductoisomerase, Clp protease and the protein transla-
tion factors EF-G and EF-Tu [4].In secondary structure prediction study, all servers
showed similar results except for Prof server. Prof server
predicted a β-sheet (residue 63–70) instead of an α-
helix, which contradicted with the other three servers.
This contradiction could be mainly caused by the small
size of the α-helix which consists of only 8 residues
(residue 63–70). It was the shortest α-helix among all
the α-helices in the built ES protein model. This second-
ary structure prediction can help in the verification for
the tertiary structure of the built protein.
The built ES protein resembled thioredoxin proteins,
consisting of four α-helices (α1- α4) flanking five mixed
β-sheets (β1- β5) in the center of the protein (Figure 2a).
Each α-helix and β-strand was connected through loops
and turns. From the ES protein structure, all the loops
and turns were located on the surface of the protein
where they could be accessed easily and have a higher
tendency to be the ES protein epitope. All four helices
were also located on the surface flanking the β-sheets,
causing the sheets to be buried in the center of the ES
protein and thus less likely to be accessible. The
β-sheets and α-helices can be subdivided into N- and
C-terminal motifs which are connected by loops. The
above mentioned orientation of the sheets, helices, loops
and turns are similar to the thioredoxin protein family.
Thus, this makes the 12 kDa ES protein a variant of
thioredoxin [28].
Thioredoxin is a single-domain monomeric glutaredoxins-
like protein with an extra β-sheet and α-helix at the
N-terminal [28]. Thioredoxin exist either in a reduced
form, with a dithiol, or in an oxidized form when its
half-cystine residues form an intramolecular disulfide
bridge [23]. The built model of the 12 kDa ES protein
model is most likely in the oxidized form because
of the presence of disulfide bridge linking two cystine
Figure 2 Built structure of 12 kDa ES protein and it’s predicted epitopes. (a) The 3-dimensional structure of the built 12 kDa ES protein
model. Purple represents α-helices, yellow represents β-sheets, white represents coils and cyan represents turns. Disulfide bond between Cys31
and Cys34 is shown in red dotted line. (b) The predicted epitopes, represented in different colors as below (Figure 2c) of the T. gondii 12 kDa ES
protein. The conserved region Trp-Cys-Gly-Pro-Cys is in stick representation. (c) Summary of the epitope prediction results of the T. gondii 12 kDa
ES protein from four sequential and conformational epitope prediction servers and protein binding site prediction results from ProBis.
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also involved in reduction/oxidization (redox) reaction
through the reversible oxidation of its active center
dithiol to a disulfide and catalyzes dithiol-disulfide
exchange reaction [23]. By having the backbone structure
of a thioredoxin protein, the ES protein is expected to
share similar functions with thioredoxins. The 12 kDa ES
protein is made of 75% β-sheets and α-helices, which issimilar in characteristic to thioredoxin protein, and
making it exceptionally stable and highly resistant to heat
[23]. Apart from that, the ES protein structure also has
the Trp-Cys-Gly-Pro-Cys conserved region (Figure 2b).
This region is possessed by thioredoxins and appears
to be the location of the disulfide bridge linking the
two cystine residues (residue 31 and 34) within the con-
served region between the β2 and α2. This conserved
Figure 3 The confirmation of the best ranked ASK1-ES protein
complex from ZDOCK. ASK1 and ES protein is in grey and yellow
cartoon representation, respectively. The residues in ES protein which
is important (Gly-32, Pro-33, Ile-74, Pro-76, Val-91, Gly-92, Ala-93) in the
binding with ASK1 are in yellow surface representation.
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protein which is known to be the active site for redox
activity [28].
Thioredoxin protein is ubiquitously expressed in all
living cells, which has a variety of biological functions
related to cell proliferation and apoptosis [29]. Thiore-
doxins are found to have anti-apoptotic effects and are
identified as an interacting partner of ASK1. Study
showed that residue Gly-32, Pro-33, Ile-74, Pro-76, Val-
91, Gly-92 and Ala-93 of thioredoxin are involved in the
binding of thioredoxin to other protein molecules [30].
From the results of the docking simulation performed
between ES protein and ASK1, all of the above men-
tioned residues (ES protein has the similar residue num-
ber) are located in the binding site of ES protein and
play a role in the binding and interaction of ES protein
with ASK1. The expression of thioredoxin interacts with
the N-terminal of ASK1 and inhibits ASK1 kinase activ-
ity and subsequent ASK1-dependent apoptosis. This
interaction is highly dependent on the redox status of
thioredoxin, indicating that the redox ability of thiore-
doxin is very important for apoptosis inhibition [31].
The molecular docking results also suggest that the ES
protein is able to bind to ASK1, thus it can possibly inhi-
biting ASK1 kinase activity which could stop the mech-
anism of ASK1-dependent apoptosis.Another study also suggested that mitochondrial thior-
edoxin is essential for cell viability and regulation of the
mitochondrial apoptosis signaling pathway [29]. A novel
thioredoxin reductase inhibitor study on human
leukemia cell lines showed inhibition activity of cell
growth and induction of apoptosis [31]. The inhibition
of ES protein could also help in the inhibition of T. gon-
dii proliferation which occurs in the tachyzoites stage.
This is because cell proliferation of T. gondii and apop-
tosis occur in the host cells during T. gondii infection.
Thus, inhibiting the ES protein could prevent cell apop-
tosis. This lead to the hypothesis that the ES protein
may play an important role in the pathogenesis of T.
gondii infection.
ES proteins are secreted by T. gondii to perform cer-
tain tasks such as invading its host cells or excreted as
waste products into the blood circulation. Thus it could
be useful for diagnostic purposes since it is expected to
be present in blood of all actively infected patients [32].
In addition, previous studies showed that the diagnostic
sensitivity and specificity of T. gondii ES antigens are
higher than the crude parasite antigen by 5% and 6% re-
spectively [10]. ES antigens are also known to improve
the sensitivity of diagnostic tools compared to somatic
antigens [11-13]. Thus, we conclude that ES antigens are
potential biomarker candidates in the development of
diagnostics for toxoplasmosis.
Epitope prediction is important to identify the binding
site of an antigen which will interact with the antibody.
Epitopes are usually located on the surface of an antigen
to make it accessible to antibodies. In addition, epitopes
also tend to be located on the loops and turns of an anti-
gen [33]. Epitopes are predicted using the calculation of
physiochemical properties of the residues and determin-
ing the residue’s antigenicity [34]. The results of epitope
predictions in this study are consistent with the basic
criteria of epitopes whereby most of the predicted epi-
topes are located in the loops and turns of the 12 kDa
ES protein. The conserved region of thioredoxin seen in
the ES protein, is one of the predicted epitopes. This re-
gion is actually conserved with Trp-Cys-X-X-Cys; where
the X represents any amino acid. If the amino acids
represented by the Xs vary in thioredoxins of different
organism, the ES protein can be a very valuable bio-
marker as the conserved region will provide a very spe-
cific binding site for an antibody. Besides that, epitope
can also be termed as “protein binding site”. Protein
binding site of the ES antigen was predicted by ProBis
[35-37], a protein binding site detection server which
detected three of the predicted epitopes as the antigen’s
binding sites, corroborating with the predicted epitopes.
An antibody does not necessarily binds to just one of
the epitopes. It might bind to more than one epitope
which are closely located in a folded protein but not in
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due 27–35, 71–76 and 91–98 in ES protein may function
as one “single” epitope to be bound with an antibody.
Predicted epitopes can be linear and/or conformational
depending on the binding mode with an antibody. All
coloured region in Figure 2(a) are considered linear epi-
topes. However, if an antibody is bound to more than
one coloured region, it can be considered as conform-
ational epitopes. These predicted epitopes can thus be
used in future design of a binder or an antibody (e.g.
scFv) which is specific to the 12 kDa ES protein.
Conclusions
A well-built 12 kDa excretory-secretory protein from
T.gondii has been constructed via homology modelling
approach. The 3-dimensional structure of the ES protein
possesses the thioredoxin backbone and conserved re-
gion. The docking simulation also showed that this ES
protein could have similar functions as thioredoxin pro-
tein. Epitopes and protein binding sites prediction from
the built structure showed constructive location on where
a specific binder could be designed to assist in the devel-
opment of an antigen-detection test for toxoplasmosis.
Methods
Secondary structure prediction
The sequence of the 12 kDa ES protein from T. gondii
was obtained from Genbank with the accession number
of ADT65352. Secondary structure prediction was per-
formed by four web-based programs namely Jpred [38],
PORTER [39], Prof [40] and APSSP2 [41].
Protein structure prediction
The sequence of the ES protein was used for Basic Local
Alignment Search Tool (BLAST) [42] against non-
redundant (nr) protein database to identify the protein
class family. BLAST was also performed using PDB
(protein data bank). The result from BLAST showed the
availability of templates with > 30% sequence identity.
Therefore, homology modeling technique was used to
build the 3D structure of the 12 kDa ES protein. Hom-
ology modeling is a reliable method to generate a 3D
model of a protein from its amino acid sequence. It
requires at least one experimentally solved 3D structure
called template that has a significant amino acid se-
quence similarity to the target sequence. Homology
modeling and experimental structure elucidation com-
plement each other [43]. A total of five templates were
selected for homology modeling technique based on the
sequence identities, sequence coverage, E-values and
crystallographic resolution. Sequence alignment of ES
protein and templates sequences was performed using
MODELLER9v8 [43-46]. A total of 200 models were
generated. Top 10 models from these 200 models wereselected based on the best molpdf score and DOPE
score. These selected 10 models were further energy
minimized to release the steric collision of atoms. A
total of 50 steps of steepest descent (SD) followed
by 50 steps of conjugate gradient (CG) energy
minimization were performed using Sander module
from AMBER8 [47].
Structure verification
All 10 minimized structures were evaluated for their
backbone conformation and stereochemical properties
by PROCHECK Ramachandran Plot [48]. Verify3D [49]
was used to validate the protein in 3D form by scoring
the possibility of each residue to exist in 3D form. Be-
sides that, G-factor value was also taken into consider-
ation in structure verification. The final model was
selected based on the best result from both Ramachan-
dran Plot and Verify3D. Secondary structure calculation
on the final model was performed by STRIDE [50].
Epitope prediction
Epitopes of the built 12 kDa ES protein were predicted
using web-based sequential epitope prediction servers i.
e. Ellipro [34] and BCPred [51,52]. Web-based conform-
ational epitope prediction servers i.e. Ellipro [34], CEP
[53] and PPI-Pred [54] were also used to predict the
conformational epitopes from the built structure. ProBis
[35-37], a protein binding site prediction swever which
detects protein binding sites based on local structural
alignment, was used to predict the protein binding sites
of the ES protein for further confirmation of the
epitopes.
Molecular docking
The protein-protein docking between apoptosis signal-
regulating kinase 1 (ASK1) (PDB ID: 2CLQ) [55] and ES
protein was performed using web-based docking servers,
ZDOCK [56], PatchDock [25,57] and FireDock [23,24].
All docking simulations were performed with the default
parameters [25,26,56].
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YBWT performed the work described in this paper and wrote the first draft
of the manuscript. RN & GS provided the raw data and edited the
manuscript. TSL participated in the experimental design and revised the
manuscript. YSC designed the experiment, gave conceptual and technical
advice, obtained the funding, coordinated the project and revised the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
We thank G. J. Tye for critical reading of the manuscript. This work was
supported by the Higher Institutions Center of Excellence (HICoE) Grant
(311/CIPPM/44001005), Graduate Assistant from University Sains Malaysia and
MyBrain Scholarship from the Malaysia Ministry of Higher Education.
Tommy et al. BMC Structural Biology 2012, 12:30 Page 8 of 9
http://www.biomedcentral.com/1472-6807/12/30Received: 5 April 2012 Accepted: 23 November 2012
Published: 27 November 2012References
1. Manikandan P, Bhaskar M, Manohar Babu B, Raghuram A, Narendran V:
Outbreak of ocular toxoplamosis in Coimbatore, India. Indian J
Ophthalmol 2006, 54:129–131.
2. Tenter AM, Heckeroth AR, Weiss LM: Toxoplasma gondii: from animals to
humans. Int J Parasitol 2000, 30:1217–1258.
3. D’ Aldebert DM, Hypolite MP, Cavailles PB, Touque BP, Flori PC, Loeuillet
CMF, Cesbron-Delauw MF: Development of High-throughput methods to
quantify cysts of Toxoplasma gondii. Cytometry Part A 2011, 79A:952–958.
4. Saadatnia G, Mohamed Z, Rifar FG, Osman E, Moghadam ZK, Noordin R:
Toxoplasma gondii excretory secretory antigen protein of diagnostic
potential. Acta Path Micro Im 2011, 120:47–55.
5. Zhou P, Chen Z, Li HT, Zheng H, He S, Lin RQ, Zhu XQ: Toxoplasma gondii
infection in humans in China. Parasit Vectors 2011, 24:168.
6. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW: Neuropsychiatric
disease and Toxoplasma gondii infection. Neuroimmunomodulat 2009,
16:122–133.
7. Health Protection Agency: Information for health professionals: toxoplasmosis.
http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/
1195733799638.
8. Torda A: Toxoplasmosis. Are cats really the source? Aust Fam Physic 2011,
30:743–747.
9. Remington JS, Thulliez P, Montoya JG: Recent development for diagnosis
of toxoplasmosis. J Clin Microbiol 2004, 42:941–945.
10. Choi M, Park IC, Li S, Hong S: Excretory-secretory antigen is better than
crude antigen for the serodiagnosis of clonorchiasis by ELISA. Korean J
Parasitol 2003, 41:35–39.
11. Gamble HR, Anderson WR, Graham CE, Murrell KD: Diagnosis of swine
trichinosis by enzyme-linked immunosorbent assay (ELISA) using
excretory-secretory antigen. Vet Parasitol 1983, 13:349–361.
12. Hassan SE, Aziz MMA: Detection of antibodies to excretory-secretory
antigen of toxocara vitulorum infective larvae in buffalo calves by ELISA.
Global Veterinaria 2010, 4:97–102.
13. Karimi GR, Abdigoudarzi M, Valizadeh M, Miranzadeh H: Comparison of
excretory-secretory and somatic antigens of ornithobilharzia
turkestanicum in agar Gel diffusion test. Iranian J Parasitol 2008, 3:19–22.
14. Bao R, Zhang Y, Zhou CZ, Chen Y: Structural and kinetic analysis of
Saccharomyces cerevisiae thioredoxin Trx1: implications for the catalytic
mechanism of GSSG reduced by the thioredoxin system. Biochim Biophys
Acta 2009, 1794:1218–1223.
15. Pinheiro AS, Amorim GC, Netto LE, Almeida FC, Valente AP: NMR solution
structure of the reduced form of thioredoxin 1 from Sacharomyces
cerevisiae. Proteins 2008, 70:584–587.
16. Bao R, Chen Y, Tang YJ, Janin J, Zhou CZ: Crystal structure of the yeast
cytoplasmic thioredoxin Trx2. Proteins 2007, 66:246–249.
17. Amorim AS, Pinheiro AS, Netto LE, Valente AP, Almeida FC: NMR solution
structure of the reduced form of thioredoxin 2 from Saccharomyces
cerevisiae. J Biomol NMR 2007, 38:99–104.
18. Xiang Z: Advances in homology protein structure modeling. Curr Protein
Pept Sci 2006, 7:217–227.
19. Baker D, Sali A: Protein structure prediction and structural genomics.
Science 2001, 294:93–96.
20. Burley SK, Bonanno JB: Structuring the universe of proteins. Annu Rev
Genomics Hum Genet 2002, 3:243–262.
21. Hooft RWW, Sander C, Vriend G: Objectively judging the quality of a
protein structure from a Ramachandran plot. Comput Appl Biosci 1997,
13:425–430.
22. Kolaskar AS, Tongaonkar PC: A semi-empirical method for prediction of
antigenic determinants on protein antigens. FEBS Lett 1990, 276:172–174.
23. Holmgren A: Thioredoxin. Ann Rev Biochem 1985, 54:237–271.
24. Hattori K, Naguro I, Runchel C, Ichijo H: The roles of ASK family proteins in
stress responses and diseases. Cell Comm Signal 2009, 7:9–17.
25. Duhovny D, Nussinov R, Wolfson HJ: Efficient unbound docking of rigid
molecules, 2’nd workshop on algorithms in bioinformatics (WABI). Rome,
Italy 2002, 2452:185–200.
26. Andrusier N, Nussinov R, Wolfson HJ: FireDock: Fast interaction refinement
in molecular docking. Proteins 2007, 69:139–159.27. Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ:
FireDock: a web server for fast interaction refinement in molecular
docking. Nucleic Acids Res 2008, 36:229–232.
28. Martin JL: Thioredoxin – a fold for all reasons. Structure 1995, 3:245–250.
29. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S,
Nishiyama A, Takeda S, Wada H, Spyrou G, Yodoi J: Thioredoxin-2 (TRX-2) is
an essential gene regulating mitochondria-dependent apoptosis. EMBO J
2002, 21:1695–1703.
30. Eklund E, Cambillau C, Sjoberg BM, Holmgren A, Jornvall H, Hoog JO,
Branden CI: Conformational and functional similarities between
glutaredoxin and thioredoxins. EMBO J 1984, 3:1443–1449.
31. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M,
Miyazono K, Ichijo H: Mammalian thioredoxin is a direct inhibitor of
apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998, 17:2596–2606.
32. Araujo FG, Handman E, Remington JS: Use of monoclonal antibodies to
detect antigens of Toxoplasma gondii in serum and other body fluids.
Infect Immun 1980, 30:12–16.
33. Davydov YI, Tonevitsky AG: Prediction of linear B-cell epitopes. Mol Biol
2009, 43:150–158.
34. Ponomarenko J, Bui H, Li W, Fusseder N, Bourne PE, Sette A, Peters B:
ElliPro: a new structure-based tool for the prediction of antibody
epitopes. BMC Bioinforma 2008, 9:514.
35. Konc J, Janezic D: ProBis algorithm for detection of structurally similar
protein binding sited by local structural alignment. Bioinformatics 2010,
26:1160–1168.
36. Konc J, Janezic D: ProBis: a web server for detection of structurally similar
protein binding sites. Nucleic Acids Res 2010, 38:436–440.
37. Weskamp N, Kuhn D, Hullermeier E, Klebe G: Efficient similarity search in
protein structure databases by k-clique hashing. Bioinformatics 2004,
20:1522–1526.
38. Cole C, Barber JD, Barton GJ: The Jpred 3 secondary structure prediction
server. Nucleic Acids Res 2008, 35:197–201.
39. Pollastri G, McLysaght A: Porter: a new, accurate server for protein
secondary structure prediction. Bioinformatics 2005, 21:1719–1720.
40. Ouali M, King RD: Cascaded multiple classifiers for secondary structure
prediction. Prot Sci 2000, 9:1162–1176.
41. Raghava GPS: APSSP2: A combination method for protein secondary
structure prediction based on neural network and example based
learning. CASP5 2002, A-132.
42. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment
search tool. J Mol Biol 1990, 215:403–410.
43. Eswar N, Eramian D, Webb B, Shen M-Y, Sali A: Protein structure modeling
with MODELLER. Methods Mol Biol 2008, 426:145–159.
44. Marti-Renom MA, Stuart A, Fiser A, Sánchez R, Sali A: Comparative protein
structure modelling of genes and genomes. Annu Rev Biophys Biomol
Struc 2000, 29:291–325.
45. Sali A, Blundell TL: Comparative protein modelling by satisfaction of
spatial restraints. J Mol Biol 1993, 234:779–815.
46. Fiser A, Do RK, Sali A: Modeling of loops in protein structures. Protein Sci
2000, 9:1753–1773.
47. Case DA, Darden TA, Cheatham TE III, Simmering CL, Wang J, Duke RE, Luo
R, Merz KM, Wang B, Pearlman DA, Crowley M, Brozell S, Tsui V, Gohlke H,
Mongan J, Hornak V, Cui G, Beroza PP, Schafmerste C, Caldwell JW, Ross WS,
Kollman PA: AMBER 8. San Francisco: University of California; 2004.
48. Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK: a
program to check the stereochemical quality of protein structures. J Appl
Crystalogr 1993, 26:283–291.
49. Luthy R, Bowie JU, Eisenberg D: Assessment of protein models with three-
dimensional profiles. Nature 1992, 356:83–85.
50. Heinig M, Frishman D: STRIDE: a web server for secondary structure
assignment from known atomic coordinates of proteins. Nucleic Acids Res
2004, 32:500–502.
51. Chen J, Lui H, Yang J, Chou K-C: Prediction of linear B-cell epitopes using
amino acid pair antigenicity scale. Amino Acids 2007, 33:423–428.
52. EL-Manzalawy Y, Dobbs D, Honavar V: Predicting linear B-cell epitopes
using string kernels. J Mol Recognit 2008, 21:243–255.
53. Kulkarni-Kale U, Bhosle S, Kolaskar AS: CEP: a conformational epitope
prediction server. Nucleic Acids Res 2005, 33:168–171.
54. Bradford JR, Westhead DR: Improved prediction of protein-protein
binding sites using a support vector machines approach. Bioinformatics
2005, 21:1487–1494.
Tommy et al. BMC Structural Biology 2012, 12:30 Page 9 of 9
http://www.biomedcentral.com/1472-6807/12/3055. Bunkoczi G, Salah E, Filippakopoulos P, Fedorov O, Muller S, Sobott F, Parker
SA, Zhang H, Min W, Turk BE, Knapp S: Structural and fuctional
characterization of the human protein kinase ASK1. Structure 2007,
15:1215–1226.
56. Chen R, Li L, Weng Z: ZDOCK: An initial-stage protein-docking algorithm.
Proteins 2003, 52:80–87.
57. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ: PatchDock and
SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res
2005, 33:363–367.
doi:10.1186/1472-6807-12-30
Cite this article as: Tommy et al.: Theoretical investigation on structural,
functional and epitope of a 12 kDa excretory-secretory protein from
Toxoplasma gondii. BMC Structural Biology 2012 12:30.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
